By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
MScannaBIZ.comMScannaBIZ.com
  • Home
  • Mississippi
  • News
    • Business
    • Culture
    • Science & Health
    • Politics
  • Cannabis Business Directory
    • Add Business listing
  • Jobs
    • Add job listings
  • Patient Resources
    • Patients & Products Seminar
  • Videos
    • Videos
  • App Download
  • Events
    • Submit your Event
  • Contact us
  • Stocks
  • The Green Room
    • Members
  • Groups
Reading: Results From One of the Largest Clinical Trials on Cannabinoids, Pain Treatment Published
Share
Sign In
Notification Show More
Latest News
L.A. Sheriff's officials update public on investigation into slain deputy
September 24, 2023
"Whilst Teams are Fazed the Band Director is Tazed."
September 24, 2023
🅽🅴🆆 Fatal Attraction 2023⛔ S13 E50 Over the Edge ⛔Fatal Attraction Full Episode✅TV One 2023
September 24, 2023
Twilio Cuts Service to Cannabis #cannabisnews #news #youtubeshorts
September 24, 2023
Can You Eat Weed? Unraveling the Truth about Consuming Raw Cannabis
September 24, 2023
Aa
MScannaBIZ.comMScannaBIZ.com
Aa
  • Home
  • Mississippi
  • News
  • Cannabis Business Directory
  • Jobs
  • Patient Resources
  • Videos
  • App Download
  • Events
  • Contact us
  • Stocks
  • The Green Room
  • Groups
Search
  • Home
  • Mississippi
  • News
    • Business
    • Culture
    • Science & Health
    • Politics
  • Cannabis Business Directory
    • Add Business listing
  • Jobs
    • Add job listings
  • Patient Resources
    • Patients & Products Seminar
  • Videos
    • Videos
  • App Download
  • Events
    • Submit your Event
  • Contact us
  • Stocks
  • The Green Room
    • Members
  • Groups
Have an existing account? Sign In
Follow US
  • Advertise
  • Blog
  • App Download
© 2022 Mississippi Cannabiz. All Rights Reserved.
MScannaBIZ.com > Cannabis Business Directory > Add Listing > News > Results From One of the Largest Clinical Trials on Cannabinoids, Pain Treatment Published
News

Results From One of the Largest Clinical Trials on Cannabinoids, Pain Treatment Published

Press Room
Press Room June 15, 2022
Updated 2022/06/15 at 6:16 PM
Share
5 Min Read
SHARE

The results of a clinical study were announced on June 15. Conducted by Radicle Science and Open Book Extracts (OBX), the study claims to be one of the largest cannabinoid trials to focus on pain treatment.

The study analyzed 1,629 U.S.-based participants over a four-week period, with the focus of examining “the synergistic impact of rare cannabinoids like Cannabichromene (CBC) and Cannabigerol (CBG) on pain.” Although there are many studies being conducted regularly on the vast topic of medical cannabis, few are conducted as a blind, randomized, controlled clinical trial.

OBX CEO Dave Neundorfer released a statement about providing scientific evidence that will help patients. “We at OBX are fundamentally dedicated to supporting all consumers in their endeavor to feel their best from the inside out through a holistic universe of effective, evidence-based cannabinoid products of the highest quality,” said Neundorfer. “While existing studies suggest that cannabidiol and rare cannabinoids, including CBG and CBC, have considerable potential to support wellness, there has been a glaring gap in scientifically valid research dedicated to guiding effective product development. That’s why we collaborated with the renowned medical experts and data scientists at Radicle Science to better understand the potential of rare cannabinoids as an ingredient and, in particular, their ability to support better quality of life outcomes relating to pain.”

Dr. Jeff Chen, MD, who is Radicle Science’s CEO as well as UCLA Cannabis Research Initiative’s founder and former Executive Director explained the importance of studies such as this one that will pave the way for medical cannabis treatments in the future. “It’s a privilege to make history with OBX,” said Chen. “Rare cannabinoids are present in a variety of health and wellness products containing cannabis and hemp, but there has been virtually no clinical data on their effectiveness for any medical condition, including pain. Radicle Science assessed for the first time in history the potential synergistic effects of certain rare cannabinoids on pain and demonstrated that these natural products can make a measurable positive impact.”

The results of “The OBX Pain Study on CBD and Rare Cannabinoids” found promising evidence of how using CBD along with other cannabinoids, known as the entourage effect, can help strengthen certain treatments. Patients were randomly selected to receive a 40 mg of CBD per serving, but some patients also received varying levels of cannabinoids such as CBG or CBC as well.

Participants were asked to report on their levels of pain, and other relative improvements to “pain severity, general activity, sleep quality, anxiety symptoms and overall quality of life.”

The results report that 44.8% of participants experienced improvement in pain, anxiety, sleep quality and quality of life. Those who experienced moderate pain and were given the 40 mg CBD as well as 20 mg CBC, saw improved pain relief when taken for more than two weeks.

According to Radicle Science Co-Founder and Executive Chair Pelin Thorogood, more studies are being planned for the future. It was promising to see that the addition of a rare cannabinoid could augment the effects of CBD,” Thorogood said. “We will be further exploring the entourage effect with an upcoming study, Radicle Spectrum, which will be the first head-to-head study comparing full or broad spectrum CBD to isolate and placebo. It is our hope this study will provide data to help the FDA ascertain whether CBD isolate is a drug.”

Other interesting studies have been published recently as well, which will continue to bolster the reputation and effectiveness of medical cannabis as a reliable treatment. One such study found evidence that weekly cannabis use has minimal impairment on physical health. A recent South Africa-based clinical trial was announced to examine the relationship between psilocybin on women with HIV and depression. Another identified that medical cannabis reduces cancer patients’ pain and need for opiate treatments.

Read the full article here

You Might Also Like

All in the Archive

Weed Isn’t Legal If You Can’t Smoke It

Pennsylvania Medical Cannabis Growers Will Now Be Able To Sell Directly To Patients Following Senate Approval 

Bitcoin Mining Farm Discovered During Chile Drug Raid

CANNRA Calls for Definitions and Regulations on Hemp

Press Room June 15, 2022
Share this Article
Facebook TwitterEmail Print
Share
What do you think?
Love0
Sad0
Happy0
Sleepy0
Angry0
Dead0
Wink0
Previous Article Body and Mind Extends Debt Financing
Next Article Editorial Roundup: Mississippi
Leave a comment Leave a comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Stay Connected

235.3k Followers Like
69.1k Followers Follow
56.4k Followers Follow
20k Subscribers Subscribe
- Advertisement -
Ad imageAd image

Latest News

L.A. Sheriff's officials update public on investigation into slain deputy
Videos September 24, 2023
"Whilst Teams are Fazed the Band Director is Tazed."
Videos September 24, 2023
🅽🅴🆆 Fatal Attraction 2023⛔ S13 E50 Over the Edge ⛔Fatal Attraction Full Episode✅TV One 2023
Videos September 24, 2023
Twilio Cuts Service to Cannabis #cannabisnews #news #youtubeshorts
Videos September 24, 2023

You Might also Like

All in the Archive

September 23, 2023
News

Weed Isn’t Legal If You Can’t Smoke It

September 22, 2023
News

Pennsylvania Medical Cannabis Growers Will Now Be Able To Sell Directly To Patients Following Senate Approval 

September 22, 2023

Bitcoin Mining Farm Discovered During Chile Drug Raid

September 22, 2023
MScannaBIZ.comMScannaBIZ.com
Follow US

© 2022 Mississippi Cannabiz. All Rights Reserved.

Removed from reading list

Undo
Welcome Back!

Sign in to your account

Register Lost your password?